Factors Potentially Associated with Chemotherapy-induced Anemia in Patients with Solid Cancers |
Cheng, Ke
(Department of Medical Oncology, Cancer Center, the State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University)
Zhao, Feng (Department of Medical Oncology, Cancer Center, the State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University) Gao, Feng (Department of Medical Oncology, Cancer Center, the State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University) Dong, Hang (Department of Medical Oncology, Cancer Center, the State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University) Men, Hai-Tao (Department of Medical Oncology, Cancer Center, the State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University) Chen, Ye (Department of Medical Oncology, Cancer Center, the State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University) Li, Long-Hao (Department of Medical Oncology, Cancer Center, the State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University) Ge, Jun (Department of Medical Oncology, Cancer Center, the State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University) Tang, Jie (Department of Medical Oncology, Cancer Center, the State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University) Ding, Jing (Department of Medical Oncology, Cancer Center, the State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University) Chen, Xin (Department of Medical Oncology, Cancer Center, the State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University) Du, Yang (Department of Medical Oncology, Cancer Center, the State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University) Luo, Wu-Xia (Department of Medical Oncology, Cancer Center, the State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University) Liu, Ji-Yan (Department of Medical Oncology, Cancer Center, the State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University) |
1 | Barrett-Lee PJ, Bailey NP, O'Brien ME, Wager E (2000). Large-scale UK audit of blood transfusion requirements and anaemia in patients receiving cytotoxic chemotherapy. Br J Cancer, 82, 93-7. DOI ScienceOn |
2 | Barrett-Lee PJ, Ludwig H, Birgegard G, et al (2006). Independent risk factors for anemia in cancer patients receiving chemotherapy: results from the European Cancer Anaemia Survey. Oncology, 70, 34-48. DOI |
3 | Bohanes P, Yang D, Chhibar RS, et al (2012). Influence of sex on the survival of patients with esophageal cancer. J Clin Oncol, 30, 2265-72. DOI |
4 | Caro JJ, Salas M, Ward A, Goss G (2001). Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review. Cancer, 91, 2214-21. DOI |
5 | Gao F, Cheng K, Zhao F, et al (2011). Prevalence and characteristics of anemia in patients with solid cancers at diagnosis in southwest China. Asian Pac J Cancer Prev, 12, 2825-8. |
6 | Groopman JE, Itri LM (1999). Chemotherapy-induced anemia in adults: incidence and treatment. J Natl Cancer Inst, 91, 1616-34. DOI |
7 | Hassan BA, Yusoff ZB (2011). Treatment patterns and outcomes in management of solid cancer patients suffering from anemia in Penang hospital. Asian Pac J Cancer Prev, 12, 1573-6. |
8 | Hassan BA, Yusoff ZB, Hassali MA, Othman SB (2011). Association and correlation of different chemotherapeutic regimens and doses with onset and severity of anemia among solid cancer patients. Asian Pac J Cancer Prev, 12, 2753-8. |
9 | Knight K, Wade S, Balducci L (2004). Prevalence and outcomes of anemia in cancer: a systematic review of the literature. Am J Med, 116, S11-26. |
10 | Kosmidis P, Krzakowski M (2005). Anemia profiles in patients with lung cancer: what have we learned from the European Cancer Anaemia Survey (ECAS)? Lung Cancer, 50, 401-12. DOI |
11 | Ludwig H, Van Belle S, Barrett-Lee P, et al (2004). The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. Eur J Cancer, 40, 2293-306. DOI |
12 | Mercadante S, Gebbia V, Marrazzo A, Filosto S (2000). Anaemia in cancer: pathophysiology and treatment. Cancer Treat Rev, 26, 303-11. DOI |
13 | Miller CB, Jones RJ, Piantadosi S, Abeloff MD, Spivak JL (1990). Decreased erythropoietin response in patients with the anemia of cancer. N Engl J Med, 322, 1689-92. DOI |
14 | Owonikoko TK, Ragin CC, Belani CP, et al (2007). Lung cancer in elderly patients: an analysis of the surveillance, epidemiology, and end results database. J Clin Oncol, 25, 5570-7. DOI |
15 | Pongsanon K, Benjapibal M, Ruengkhachorn I (2011). Prognostic significance of hemoglobin levels in patients with primary epithelial ovarian carcinoma undergoing platinumbased chemotherapy. Asian Pac J Cancer Prev, 12, 131-6. |
16 | Rothmann SA, Weick JK (1981). Cisplatin toxicity for erythroid precursors. N Engl J Med, 304, 360. |
17 | Spivak JL, Gascon P, Ludwig H (2009). Anemia management in oncology and hematology. Oncologist, 14, 43-56. DOI |
18 | Steensma DP (2008). Is anemia of cancer different from chemotherapy-induced anemia? J Clin Oncol, 26, 1022-4. DOI |
19 | Tchekmedyian NS (2002). Anemia in cancer patients: significance, epidemiology, and current therapy. Oncology (Williston Park), 16, 17-24. |
20 | Weiss G, Goodnough LT (2005). Anemia of chronic disease. N Engl J Med, 352, 1011-23. DOI |
21 | Wilairat W, Benjapibal M (2012). Presence of anemia and poor prognostic factors in patients with endometrial carcinoma. Asian Pac J Cancer Prev, 13, 3187-90. 과학기술학회마을 DOI ScienceOn |
22 | Achariyapota V, Benjapibal M, Chaopotong P (2010). Prevalence and incidence of anemia in Thai patients with gynecologic cancer. Asian Pac J Cancer Prev, 11, 1229-33. |
23 | Aapro M, Jelkmann W, Constantinescu SN, Leyland- Jones B (2012). Effects of erythropoietin receptors and erythropoiesis-stimulating agents on disease progression in cancer. Br J Cancer, 106, 1249-58. DOI |
24 | Aapro M, Osterborg A, Gascon P, Ludwig H, Beguin Y (2012). Prevalence and management of cancer-related anaemia, iron deficiency and the specific role of i.v. iron. Ann Oncol, 23, 1954-62. DOI |
25 | Abdel-Razeq HN (2004). Cancer-related anemia. Saudi Med J, 25, 15-20. |